『海外』Weekly ニュース (2023/05/22 ～ )

🚩 あれ？リンクがない？！
※ ログインのご案内
本記事２ページ目には、各情報へのURL(リンク) ならびに 編集部コメント[ Editor's 👀 Eye ] が追記されています。
是非とも(無料)会員登録の上、ログインしてご利用ください。

(登録 2023/05/30)

📢  (https://)
Guizhou uses big data tech to develop smart healthcare (https://)

 

(登録 2023/05/30)

📢 BenchSci (Scinapsis Analytics Inc.) (https://)
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND (https://)

📢 Viva Vita Company (https://)
Revolutionizing Senior Healthcare with Virtual Reality, Viva Vita and Waya Health Announce Partnership (https://)

📢 BIOSENCY (https://)
Biosency detects early COPD exacerbations thanks to Bora care®, a predictive digital medical device (https://)

📢 Medtronic plc (https://)
Medtronic to acquire wearable insulin patch maker EOFlow (https://)

📢 Nox Health (https://)
Nox Health acquires Somryst, the only FDA-cleared digital insomnia treatment, further elevating its behavioral sleep care management program. (https://)

 

(登録 2023/05/30)

📢 H1 Insights, Inc. (https://)
H1 Partners with The Michael J. Fox Foundation to Transform Parkinson’s Disease Studies (https://)

📢 Noom, Inc. (https://)
Noom, Inc. Launches Noom Med, A Best-in-Class Individualized Obesity Care Program Powered by Biology and Psychology (https://)

📢 Adjoin (https://)
Nonprofit Adjoin Launches Path-Now, an Innovative Application and Service Provider Network for Individuals with Disabilities (https://)

📢 National Sleep Foundation (https://)
National Sleep Foundation Highlights Evidence in General US Population Connecting Sleep Health with Probable Depressive Disorder (https://)

📢 Summus Global, Inc. (https://)
Summus Announces Collaboration with Leal Health (https://)

📢 MDVIP, LLC (https://)
Two-Thirds of Americans Are Living With Gut Issues, Unaware of the Health Consequences (https://)

📢 Omada Health Inc. (https://)
Omada Health Launches GLP-1-Specific Program for Patients Battling Chronic Obesity (https://)

 

(登録 2023/05/30)

📢 TrialSpark, Inc. (https://)
TrialSpark Announces First Patient Dosed in Phase 2 Clinical Trial for ASN008-201 in Atopic Dermatitis (https://)

📢 Shenzhen SIBIONICS Technology CO., LTD (https://)
Shenzhen SiBionics Co., Ltd. to apply for CE certification for SIBIONICS CGM (https://

📢 BrightInsight, Inc. (https://)
BrightInsight Named 2023 Global Company of the Year by Frost & Sullivan for Enabling Better Patient Outcomes with Digital Solutions (https://)

📢 Tell Health Inc. (https://)
Tell™ Social Media App Integrates ChatGPT Generative Artificial Intelligence Feature for All Verified Physicians and Providers (https://)

📢 Research and Markets
Mindfulness Meditation Applications Global Market Report 2023: VR-Based Meditation Apps Present Opportunities (https://)

📢 OMRON Healthcare Co., Ltd.
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History (https://)

(登録 2023/05/24)

📢 Linus Health, Inc. (https://)
New Research Shows Power of Linus Health’s Cognitive Assessment Technology to Identify Cognitive Impairment That Traditional Tests Miss (https://)

📢 Sonde Health, Inc. (https://)
Sonde Health's Respiratory Responsive Vocal Biomarker Tool Differentiates Patients with Respiratory Conditions from Healthy Individuals (https://)

📢 iHealthScreen Inc. (https://)
iHealthScreen Inc. Announces FDA 510K Submission for iPredict™ AMD tool – An Automated AI-based Software as a Medical Device for Early Diagnosis of Age-Related Macular Degeneration (AMD) (https://)

 

(登録 2023/05/30)

📢 Orlucent, Inc. (https://)
Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System (https://)

📢 Research and Markets
Metaverse in Healthcare Market Report 2023: Increasing Adoption of Mixed Reality for Performing Minimally Invasive Surgeries Bolsters Growth (https://)

(登録 2023/05/24)

📢 ZoomRx Inc. (https://)
ZoomRx Announces Launch of Ferma: The First AI-Powered Ally Uniquely Crafted to Empower Life Sciences Professionals (https://)

📢 Exscientia plc (https://)
ExscientiaがSLAS Europeで「AIを活用した創薬の未来」を強調 (https://)
最新技術の進歩で、創薬、発見、開発を革新する。
新型自動発見実験室 2023年に開設予定

 

以上